Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm

  • SAURABH KUMAR
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • AKIRA FUJII
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • SUNIL KAPUR
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • JORGE ROMERO
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • NISHAKI K. MEHTA
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • SHINICHI TANIGAWA
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • LAURENCE M. EPSTEIN
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • BRUCE A. KOPLAN
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • GREGORY F. MICHAUD
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • ROY M. JOHN
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • WILLIAM G. STEVENSON
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA
  • USHA B. TEDROW
    Cardiovascular Division Brigham and Women's Hospital Boston Massachusetts USA

この論文をさがす

説明

<jats:title>Differences in VT Storm versus Nonstorm Patients</jats:title><jats:sec><jats:title>Aims</jats:title><jats:p>Catheter ablation can be lifesaving in ventricular tachycardia (VT) storm, but the underlying substrate in patients with storm is not well characterized. We sought to compare the clinical factors, substrate, and outcomes differences in patients with sustained monomorphic VT who present for catheter ablation with VT storm versus those with a nonstorm presentation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Consecutive ischemic (ICM; n = 554) or nonischemic cardiomyopathy patients (NICM; n = 369) with a storm versus nonstorm presentation were studied (ICM storm 186; NICM storm 101).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In ICM, storm compared with nonstorm patients had significantly lower left ventricular (LV) ejection fraction (EF), greater number of antiarrhythmic drug (AAD) failures, slower VTs, greater number of scarred LV segments, higher incidence of anterior, septal, and apical endocardial LV scar (all P < 0.05). However, outcomes in follow‐up were similar (12‐month ventricular arrhythmia [VA]‐free survival: 51% vs. 52%, P = 0.6; survival free of death/transplant 75% vs. 87%, P = 0.7). In addition to the above differences, NICM storm patients were also older; however, the extent and distribution of scar was similar except for a higher incidence of lateral endocardial scar in storm patients (P = 0.05). VA‐free survival (36% vs. 47%, P = 0.004) and survival free of death/transplant, however, were worse in NICM storm than nonstorm patients (72% vs. 88%, P = 0.001). NICM storm patients had worse VA‐free survival than ICM storm patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>There are differences in clinical factors and scar patterns in patients undergoing VT ablation who present with VT storm versus those with a nonstorm presentation. Clinical outcomes are worse in NICM storm patients.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ